Patents by Inventor Thomas Langer

Thomas Langer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140228339
    Abstract: There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.
    Type: Application
    Filed: April 15, 2014
    Publication date: August 14, 2014
    Applicant: AstraZeneca AB
    Inventors: Stephen Connolly, Mark Richard Ebden, Iain Alastair Stewart Walters, Thomas Langer, Alan Robert Steven, Craig Robert Stewart, Paula Margaret Tomlin, Andrew John Williams
  • Patent number: 8735413
    Abstract: There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: May 27, 2014
    Assignee: AstraZeneca AB
    Inventors: Stephen Connolly, Mark Richard Ebden, Iain Alastair Stewart Walters, Thomas Langer, Alan Robert Steven, Craig Robert Stewart, Paula Margaret Tomlin, Andrew John Williams
  • Publication number: 20140073563
    Abstract: The invention is directed to a fusion protein comprising at least one FGF-21 (fibroblast growth factor-21) compound and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist as well as to pharmaceutical compositions, medical uses and methods of treatment involving the fusion protein, particularly in the field of diabetes, dyslipidemia, obesity and/or adipositas.
    Type: Application
    Filed: September 6, 2013
    Publication date: March 13, 2014
    Applicant: SANOFI
    Inventors: Oliver BOSCHEINEN, Matthias DREYER, Paul HABERMANN, Hans-Ludwig SCHAEFER, Mark SOMMERFELD, Thomas LANGER
  • Publication number: 20130312865
    Abstract: A double-wall pipe for a transportation means which includes an outer pipe and an inner pipe extending therein. The outer pipe has two pipe segments which are formed like half-shells and are joined together to form the outer pipe along the longitudinal edges thereof. In this way, it is possible to make both the outer pipe and the inner pipe of metal, such that the wall thickness of the inner pipe can be relatively small.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Inventors: Alexander Baur, Christoph Heimerdinger, Roland Lang, Thomas Langer, Heinz Meister, Josef Messner, Dirk Schwarze
  • Patent number: 8555305
    Abstract: Providing a reward as an incentive for a person to become an audience member of at least one program being performed by reproduction equipment. A programming signal used for broadcasting the program with a programming signal source is encoded with discrete code signals, such that a preset number of the code signals occur within a given period of time, to produce an output signal which is broadcast. The broadcast output signal is received, and the code signals therein are detected. The number of the code signals detected while the person is an audience member of the at least one program is compared with predetermined reward issuance criteria. A reward is issued when the reward issuance criteria are met by the number of detected code signals.
    Type: Grant
    Filed: March 19, 2003
    Date of Patent: October 8, 2013
    Assignee: Winmore, Inc.
    Inventors: Lee S. Weinblatt, Thomas Langer
  • Publication number: 20130189714
    Abstract: The invention refers to methods for detecting and/or quantifying the interaction of platelets or platelet surface molecules with an interaction partner, methods for detecting and/or quantifying the capability of a test substance to modulate the interaction of platelets or platelet surface molecules with interaction partners and articles or manufacture.
    Type: Application
    Filed: September 19, 2011
    Publication date: July 25, 2013
    Applicant: SANOFI
    Inventors: Meltsje De Hoop, Klaus Lindauer, Ulrike Lukasczyk, Horst Blum, Thomas Langer, Marion Zerlin
  • Publication number: 20130040926
    Abstract: There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.
    Type: Application
    Filed: July 11, 2012
    Publication date: February 14, 2013
    Inventors: Stephen CONNOLLY, Mark Richard EBDEN, Iain Alastair Stewart WALTERS, Thomas LANGER, Alan Robert STEVEN, Craig Robert STEWART, Paula Margaret TOMLIN, Andrew John WILLIAMS
  • Publication number: 20120282710
    Abstract: The present invention relates to an isolated protein comprising a ligand binding domain of a nuclear receptor in controllable form, a method of producing the same, its use for the identification of a ligand, a test system comprising the isolated protein and a method for screening for a ligand for a nuclear receptor using the test system.
    Type: Application
    Filed: July 17, 2012
    Publication date: November 8, 2012
    Applicant: SANOFI
    Inventors: Uwe SCHWAHN, Thomas LANGER
  • Publication number: 20120244152
    Abstract: The present invention discloses novel antibodies that specifically bind to the human platelet membrane protein Glycoprotein VI (GPVI) and their monovalent fragments or derivatives. The antibodies of the invention are antibodies from hybridoma clone 390 and fragment antibodies thereof able to induce a GPVI depletion pheno-type. These antibodies and Fab fragments are able to block collagen binding and thus preventing platelet activation by collagen. The invention also relates to hybridoma clones and expression plasmids for the production of disclosed antibodies and Fab fragments. The present invention further refers to the uses of monovalent antibody fragments to manufacture research, diagnostic and immunotherapeutic agents for the treatment of thrombosis and other vascular diseases. The invention also concerns a Fab bearing a molecule at the C-terminal extremity, as well as method for prevention of recognition of Fab by antibodies using such modified Fab.
    Type: Application
    Filed: December 17, 2010
    Publication date: September 27, 2012
    Applicant: SANOFI
    Inventors: Nicolas Baurin, Francis Blanche, Beatrice Cameron, Carsten Corvey, Tarik Dabdoubi, Christian Engel, Peter Florian, Ingo Focken, Katja Kroll, Jochen Kruip, Christian Lange, Thomas Langer, Martin Lorenz, Vincent Mikol, Ercole Rao, Peter Wonerow
  • Patent number: 8170211
    Abstract: The invention relates to a node device (21) for a network (20) comprising quantum cryptographic connections (1) provided with quantum channels (4) and public channels (5), comprising quantum optics means (11) for connecting to the respective quantum channels, for generating secrets or keys by means of quantum cryptography, comprising means (13) for managing symmetrical secrets or keys, cryptography means (14) for generating cryptograms, and driver means (15) connected thereto for transmission via a public channel, wherein the means (15) for managing symmetrical secrets or keys and the cryptography and driver means (14; 15) are combined in a common node module (24) as central components (13, 14, 15) for a plurality of quantum channel connections, while the quantum optics means (11) are provided separately in decentral modules (23) for the plurality of quantum channel connections.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: May 1, 2012
    Assignee: Austrian Research Centers GmbH-ARC
    Inventor: Thomas Langer
  • Publication number: 20110177611
    Abstract: The present invention relates to an isolated protein comprising a ligand binding domain of a nuclear receptor in controllable form, a method of producing the same, its use for the identification of a ligand, a test system comprising the isolated protein and a method for screening for a ligand for a nuclear receptor using the test system.
    Type: Application
    Filed: September 13, 2008
    Publication date: July 21, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Uwe Schwahn, Thomas Langer
  • Patent number: 7950031
    Abstract: An interactive technique for generating a supplementary, program-related output. A programming signal and a supplementary, program-related data signal are combined into a broadcast signal which is then broadcast from a program signal source. The broadcast signal is received, and the programming signal of the received broadcast signal is performed with reproduction equipment for an audience. The supplementary, program-related data signal of the received broadcast signal is stored, and retrieval of the stored supplementary, program-related data signal is enabled interactively with the programming signal being performed. In response to a control signal being actuated by a member of the audience tuned to the programming signal being performed, the stored supplementary, program-related data signal is retrieved and used to generate the supplementary, program-related output.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: May 24, 2011
    Inventors: Lee S. Weinblatt, Thomas Langer
  • Publication number: 20100209436
    Abstract: The present invention relates to means and methods for therapeutic intervention of mitochondrial disorders or diseases, in particular to a method for the treatment, prevention and/or amelioration of a disorder or disease correlated with mitochondrial dysfunction, a mitochondrial disorder or disease or a disorder or disease characterized by an altered OPA1 processing. Thereby, a pharmaceutically active amount of a compound capable of modulating the activity of an oligomeric complex comprising Afg3I1 and/or Afg3I2 or (a) variant(s) thereof is administered to a patient in need of medical intervention. The present invention also relates to the use of an oligomeric complex comprising Afg3I1 and/or Afg3I2 or (a) variant(s) thereof for the preparation of a pharmaceutical composition for the mentioned therapeutic intervention.
    Type: Application
    Filed: July 2, 2008
    Publication date: August 19, 2010
    Inventors: Andreas Reichert, Stéphane Duvezin-Caubet, Johannes Wagener, Michael Zick, Thomas Langer, Mirko Koppen, Walter Neupert
  • Publication number: 20090279698
    Abstract: The invention relates to a node device (21) for a network (20) comprising quantum cryptographic connections (1) provided with quantum channels (4) and public channels (5), comprising quantum optics means (11) for connecting to the respective quantum channels, for generating secrets or keys by means of quantum cryptography, comprising means (13) for managing symmetrical secrets or keys, cryptography means (14) for generating cryptograms, and driver means (15) connected thereto for transmission via a public channel, wherein the means (15) for managing symmetrical secrets or keys and the cryptography and driver means (14; 15) are combined in a common node module (24) as central components (13, 14, 15) for a plurality of quantum channel connections, while the quantum optics means (11) are provided separately in decentral modules (23) for the plurality of quantum channel connections.
    Type: Application
    Filed: June 27, 2007
    Publication date: November 12, 2009
    Applicant: AUSTRIAN RESEARCH CENTERS GMBH-ARC
    Inventor: Thomas Länger
  • Publication number: 20090077593
    Abstract: An interactive technique for generating a supplementary, program-related output. A programming signal and a supplementary, program-related data signal are combined into a broadcast signal which is then broadcast from a program signal source. The broadcast signal is received, and the programming signal of the received broadcast signal is performed with reproduction equipment for an audience. The supplementary, program-related data signal of the received broadcast signal is stored, and retrieval of the stored supplementary, program-related data signal is enabled interactively with the programming signal being performed. In response to a control signal being actuated by a member of the audience tuned to the programming signal being performed, the stored supplementary, program-related data signal is retrieved and used to generate the supplementary, program-related output.
    Type: Application
    Filed: November 21, 2008
    Publication date: March 19, 2009
    Inventors: Lee S. Weinblatt, Thomas Langer
  • Patent number: 7155159
    Abstract: An audience surveying technique for identifying individual members of an audience listening to and/or watching a program performed from a programming signal source. A stationary apparatus is operatively arranged at a reception location with a plurality of portable devices designed to be worn by the audience members. The stationary apparatus detects and stores a surveying code transmitted with the program, and it also periodically emits a trigger signal which causes the portable devices to respond by emitting a unique identification signal pre-stored in each one. The stationary apparatus also detects and stores the identification signals. By associating the detected surveying code with the detected identification signals it is possible to quickly, accurately and reliably identify the individual audience members tuned to a particular program.
    Type: Grant
    Filed: March 6, 2000
    Date of Patent: December 26, 2006
    Inventors: Lee S. Weinblatt, Thomas Langer
  • Publication number: 20060170903
    Abstract: A range finder system for determining a range of an object. The system includes a source of laser radiation configured for transmitting a plurality of pulses, a first detector, a second detector, an optical arrangement configured for directing the pulses along an outgoing path and receiving the pulses reflected by the object along a return path. The first detector is deployed to be responsive to the pulses traveling along the outgoing path and the second detector insensitive to the reflections of the pulses from less that the minimum range. The system further includes a controller configured for shorting a connection within the second detector to make the second detector insensitive to the reflections of the pulses from less than a minimum range, and for determining the range of the object based upon a time-of-flight of one or more of the pulses based upon output signals of the first detector and the second detector.
    Type: Application
    Filed: January 24, 2006
    Publication date: August 3, 2006
    Inventors: Shimon Aburmad, Ehud Chishinski, Thomas Langer
  • Patent number: 6993284
    Abstract: A method and apparatus for, interactively with a broadcast program that is being performed, enabling access to supplementary materials related to the program from a broadcast signal that is a combination of a programming signal and a supplementary materials signal. The broadcast output signal is received at a location of an audience. The programming signal of the received output signal is performed for the audience, with reproduction equipment. A signal related to the supplementary material signal is extracted from the received broadcast signal. Access to the supplementary material corresponding to the supplementary material signal is enabled in response to an interactive control signal actuated by a member of the audience tuned to the programming signal being performed, and based on the extracted signal.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: January 31, 2006
    Inventors: Lee S. Weinblatt, Thomas Langer
  • Publication number: 20060020963
    Abstract: A technique for enabling access to supplementary materials related to a program that is broadcast to a plurality of audience members. A programming signal is obtained to be used for performing the program. A supplementary material ID signal is obtained that uniquely identifies particular program-related supplementary material from among a plurality of available program-related supplementary materials, but which does not include sufficient data for printing and/or displaying such particular program-related supplementary material. The programming signal and the supplementary material ID signal are combined into an output signal that is broadcast from a broadcast signal source.
    Type: Application
    Filed: July 8, 2005
    Publication date: January 26, 2006
    Applicant: Lee S. Weinblatt
    Inventors: Lee Weinblatt, Thomas Langer
  • Patent number: 6782491
    Abstract: Apparatus and method for the power supply of auxiliary implements of computers via the bus system of the computer, wherein an energy store is provided within the auxiliary implements, which is supporting the power supply of the auxiliary implement and which by means of a suitable charge circuit is connected to the power supply in the bus system of the computer.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: August 24, 2004
    Assignee: Infineon Technologies AG
    Inventors: Dieter Foedlmeier, Thomas Langer, Stefan Seidenberg